245 related articles for article (PubMed ID: 6060717)
21. [Steroid and immunosuppressive therapy in primary glomerular nephropathy (glomerulonephritis) in adults. Clinical and nephrobioptic study].
Bonomini V; Mioli V; Albertazzi A; Vangelista A
Minerva Nefrol; 1969; 16(2):103-19. PubMed ID: 5398499
[No Abstract] [Full Text] [Related]
22. [Complications of immunosuppresive therapy in chronic nephropathies in children].
Sasinka M; Plenta I; Pavlovic M; Izakovic V; Kaiserová E; Páleníková O; Stubna J
Cesk Pediatr; 1976 Mar; 31(3):122-6. PubMed ID: 1269009
[No Abstract] [Full Text] [Related]
23. [Indications and limitations of immunosuppressive therapy in chronic glomerulonephritis].
Ponticelli C; Brancaccio D; Locatelli F; Imbasciati E
Minerva Nefrol; 1969; 16(3):228-34. PubMed ID: 5356052
[No Abstract] [Full Text] [Related]
24. "Immunosuppressive" treatment of "chronic glomerulonephritis".
Kallen RJ; Lewis EJ
J Pediatr; 1973 Feb; 82(2):335-9. PubMed ID: 4567554
[No Abstract] [Full Text] [Related]
25. [Cytostatic treatment of the steroid-resistant nephrotic syndrome. (Long term study on 24 patients)].
Oechslen D; Kluthe R; Sarre H
Arch Klin Med; 1968; 215(2):150-60. PubMed ID: 5718136
[No Abstract] [Full Text] [Related]
26. Therapeutic trials in renal disease.
Black DA
Anglo Ger Med Rev; 1972 Mar; 6(3):97-101. PubMed ID: 4570438
[No Abstract] [Full Text] [Related]
27. [Use of cyclophosphamide in membranoproliferative glomerulonephritis].
Wills H; Villarreal H
Arch Inst Cardiol Mex; 1976; 46(6):770-5. PubMed ID: 1023835
[TBL] [Abstract][Full Text] [Related]
28. Efficacy of steroids, cyclosporin and cyclophos-phamide in steroid resistant idiopathic nephrotic syndrome.
Hafeez F; Ahmad TM; Anwar S
J Coll Physicians Surg Pak; 2005 Jun; 15(6):329-32. PubMed ID: 15924835
[TBL] [Abstract][Full Text] [Related]
29. Extracapillary glomerulonephritis in a patient with juvenile chronic arthritis.
Mertens JC; Huizinga TW; Hagen EC; Hollander AA; Peeters AJ; Bruijn JA; MacFarlane JD; Dijkmans BA
J Rheumatol; 1996 Sep; 23(9):1633-5. PubMed ID: 8877937
[TBL] [Abstract][Full Text] [Related]
30. [Amino acid metabolism in steroid therapy of nephropathies].
Pyrig LA; Nikula TD
Vrach Delo; 1969 Feb; 2():135-7. PubMed ID: 5779366
[No Abstract] [Full Text] [Related]
31. [Anti-inflammatory activity of glucocorticoids in nephrology].
Nykula TD; Bondur VV; Moĭseienko VO; Aleksieieva NH
Lik Sprava; 2013; (5):94-8. PubMed ID: 24605641
[TBL] [Abstract][Full Text] [Related]
32. The therapeutic value of steroids in the nephrotic syndrome.
Greifer I
Transplant Proc; 1975 Mar; 7(1):102-7. PubMed ID: 1118890
[No Abstract] [Full Text] [Related]
33. [Effects of cyclophosphamide on the length of remission in patients suffering from glomerulonephritis with nephrotic syndrome].
Duman VL; Shkerina LI; Shilov EM
Klin Med (Mosk); 2005; 83(10):48-50. PubMed ID: 16320847
[TBL] [Abstract][Full Text] [Related]
34. Cytotoxic agents in childhood glomerulonephritis.
Barratt M
Arch Dis Child; 1972 Apr; 47(252):159-62. PubMed ID: 4554082
[No Abstract] [Full Text] [Related]
35. [Comparison of two cyclophosphamide treatment regimens in nephrotic patients with chronic glomerulonephritis].
Krasnova TN; Shilov EM; Tareeva IE; Gordovskaia NB; Lavrova ON; Miroshnichenko NG; Troepol'skaia OV; Ivanova LV; Ivanov AA
Ter Arkh; 1998; 70(6):14-7. PubMed ID: 9695216
[TBL] [Abstract][Full Text] [Related]
36. [Treatment of chronic glomerulopathy].
Orlowski T; Gradowska L; Lao M; Rancewicz Z; Rowinska D
Z Gesamte Inn Med; 1972 Nov; 27(22):980-3. PubMed ID: 4649659
[No Abstract] [Full Text] [Related]
37. [Comparison of the effectiveness of Cyclophosphamide and Cytembena in controlled clinical trial in nephrotic syndrome and chronic glomerulonephritis].
Sasinka M; Plenta I; Kaiserová E; Izakovic V; Pavlovic M; CYTEMBENA/*THER USE ; Slugen I; Lehký M; Stubna J
Cesk Pediatr; 1976 Mar; 31(3):127-30. PubMed ID: 773556
[No Abstract] [Full Text] [Related]
38. [Immunosuppressive therapy (cytostatics) in glomerulonephritis].
Ricken D
Verh Dtsch Ges Inn Med; 1972; 78():766-70. PubMed ID: 4665751
[No Abstract] [Full Text] [Related]
39. [Genetically determined variability in cell glucocorticoid receptors as a factor in sensitivity to glucocorticoid therapy in the nephrotic syndrome].
Liashko VN; Grinberg KN; Mukhin NA; Dziuba MT
Vestn Akad Med Nauk SSSR; 1980; (6):28-32. PubMed ID: 7405376
[No Abstract] [Full Text] [Related]
40. [Long-time treatment of chronic glomerulonephritis with azathioprine].
Schnaars P; Spühler O
Helv Med Acta Suppl; 1966 May; 46():137. PubMed ID: 5286257
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
